You are here

Bydureon

FDA offers former biotech unicorn Intarcia a chance for a panel review

BioPharma Dive

Thu, 02/9/23 - 06:04 pm

ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes

Fierce Pharma

Fri, 06/25/21 - 12:16 pm

type 2 diabetes

clinical trials

How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes

Fierce Biotech

Thu, 02/13/20 - 10:44 am

How Big Can This $8 Billion-Plus Diabetes Drug Class Get?

Motley Fool

Fri, 09/27/19 - 09:10 am

Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease

Fierce Biotech

Tue, 07/24/18 - 10:32 am

Parkinson's Disease

ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study

Fierce Pharma

Mon, 06/25/18 - 09:07 pm

AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval

Drug Delivery Business News

Tue, 04/3/18 - 10:52 pm

FDA clears AstraZeneca’s once-weekly Type II diabetes drug-device combo

Drug Delivery Business News

Mon, 10/23/17 - 10:01 am

drug-device combos

AstraZeneca's Bydureon fails to show cardio-protection

BioPharma Dive

Thu, 09/14/17 - 10:05 pm

AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?

Fierce Pharma

Tue, 05/23/17 - 08:17 am

Next stop in AstraZeneca fire sale: China

BioPharma Dive

Thu, 10/13/16 - 03:27 pm

AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes

Yahoo

Sun, 06/12/16 - 12:29 pm

clinical trials

type 2 diabetes

Novo's weekly diabetes drug clears another Phase III hurdle

Fierce Biotech

Fri, 09/25/15 - 08:45 pm

Bydureon, Invokana, Xarelto brand teams shelled out most to doctors in 2014

Fierce Pharma Marketing

Wed, 07/8/15 - 11:34 am

physician payments

After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin

Seeking Alpha

Wed, 04/2/14 - 09:52 pm

Bristol-Myers Squibb

AstraZeneca announces FDA approval of Bydureon Pen

The Fly on the Wall

Mon, 03/3/14 - 10:05 am

FDA eases worries regarding certain diabetes medications

Yahoo/Fly on the Wall

Thu, 02/27/14 - 08:19 am

Bristol-Myers Squibb

Who loses most in Lilly vs. Novo diabetes study? AstraZeneca

Fierce Pharma

Wed, 02/26/14 - 07:03 pm

Clock Is Ticking For AstraZeneca

Forbes

Tue, 02/25/14 - 03:57 pm

AstraZeneca, Bristol Recall Bydureon Diabetes Drug For Under-Filled Vials

WSJ Online

Fri, 09/20/13 - 10:20 am

Bristol-Myers Squibb

Pages